Cargando…
Protective Effect of Lactobacillus diolivorans 1Z, Isolated From Brazilian Kefir, Against Salmonella enterica Serovar Typhimurium in Experimental Murine Models
Kefir is a beverage obtained by fermentation of milk or sugar solution by lactic acid bacteria and yeasts, and several health benefits have been attributed to its ingestion, part of them being attributed to Lactobacillus species. The objective of the present study was to evaluate, in vivo, the probi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288297/ https://www.ncbi.nlm.nih.gov/pubmed/30564201 http://dx.doi.org/10.3389/fmicb.2018.02856 |
_version_ | 1783379770754465792 |
---|---|
author | Abatemarco Júnior, Mario Sandes, Sávio Henrique Cicco Ricci, Mayra Fernanda Arantes, Rosa Maria Esteves Nunes, Álvaro Cantini Nicoli, Jacques Robert Neumann, Elisabeth |
author_facet | Abatemarco Júnior, Mario Sandes, Sávio Henrique Cicco Ricci, Mayra Fernanda Arantes, Rosa Maria Esteves Nunes, Álvaro Cantini Nicoli, Jacques Robert Neumann, Elisabeth |
author_sort | Abatemarco Júnior, Mario |
collection | PubMed |
description | Kefir is a beverage obtained by fermentation of milk or sugar solution by lactic acid bacteria and yeasts, and several health benefits have been attributed to its ingestion, part of them being attributed to Lactobacillus species. The objective of the present study was to evaluate, in vivo, the probiotic potential of Lactobacillus diolivorans 1Z, isolated from Brazilian kefir grains. Initially, conventional mice were orally treated daily or not during 10 days with a suspension of L. diolivorans 1Z, and then orally challenged with Salmonella enterica serovar Typhimurium. Treatment with L. diolivorans 1Z resulted in higher survival (70%) of animals after the challenge with the pathogen than for not treated mice (0%). When germ-free mice were monoassociated (GN-PS group) or not (GN-CS group) with L. diolivorans 1Z and challenged after 7 days with S. Typhimurium, Salmonella fecal counts were significantly lower (P < 0.05) for the GN-PS group when compared to the GN-CS group. Histopathological analysis revealed less damage to the ileum mucosa, as demonstrated by smallest perimeter of major lesions for mice of the GN-PS group in comparison to the group GN-CS (P < 0.05). These findings were accompanied by a lower expression of IFN-γ and TNF-α in the intestinal tissue of GN-PS mice. Additionally, translocation of S. Typhimurium to liver was significantly lower in GN-PS than in GN-CS mice (P < 0.05), and IgA levels in intestinal content and number of Kupffer cells in liver were higher. No difference was observed for hepatic cellularity between GN-PS and GN-CS groups (P > 0.05), but the pattern of inflammatory cells present in the liver was predominantly of polymorphonuclear in GN-CS group and of mononuclear in the GN-PS group, and a higher hepatic expression of IL-10 and TGF-β was observed in GN-PS group. Concluding, L. diolivorans 1Z showed to be a potential probiotic strain that protected mice from death after challenge with S. Typhimurium, apparently by immunological modulation. |
format | Online Article Text |
id | pubmed-6288297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62882972018-12-18 Protective Effect of Lactobacillus diolivorans 1Z, Isolated From Brazilian Kefir, Against Salmonella enterica Serovar Typhimurium in Experimental Murine Models Abatemarco Júnior, Mario Sandes, Sávio Henrique Cicco Ricci, Mayra Fernanda Arantes, Rosa Maria Esteves Nunes, Álvaro Cantini Nicoli, Jacques Robert Neumann, Elisabeth Front Microbiol Microbiology Kefir is a beverage obtained by fermentation of milk or sugar solution by lactic acid bacteria and yeasts, and several health benefits have been attributed to its ingestion, part of them being attributed to Lactobacillus species. The objective of the present study was to evaluate, in vivo, the probiotic potential of Lactobacillus diolivorans 1Z, isolated from Brazilian kefir grains. Initially, conventional mice were orally treated daily or not during 10 days with a suspension of L. diolivorans 1Z, and then orally challenged with Salmonella enterica serovar Typhimurium. Treatment with L. diolivorans 1Z resulted in higher survival (70%) of animals after the challenge with the pathogen than for not treated mice (0%). When germ-free mice were monoassociated (GN-PS group) or not (GN-CS group) with L. diolivorans 1Z and challenged after 7 days with S. Typhimurium, Salmonella fecal counts were significantly lower (P < 0.05) for the GN-PS group when compared to the GN-CS group. Histopathological analysis revealed less damage to the ileum mucosa, as demonstrated by smallest perimeter of major lesions for mice of the GN-PS group in comparison to the group GN-CS (P < 0.05). These findings were accompanied by a lower expression of IFN-γ and TNF-α in the intestinal tissue of GN-PS mice. Additionally, translocation of S. Typhimurium to liver was significantly lower in GN-PS than in GN-CS mice (P < 0.05), and IgA levels in intestinal content and number of Kupffer cells in liver were higher. No difference was observed for hepatic cellularity between GN-PS and GN-CS groups (P > 0.05), but the pattern of inflammatory cells present in the liver was predominantly of polymorphonuclear in GN-CS group and of mononuclear in the GN-PS group, and a higher hepatic expression of IL-10 and TGF-β was observed in GN-PS group. Concluding, L. diolivorans 1Z showed to be a potential probiotic strain that protected mice from death after challenge with S. Typhimurium, apparently by immunological modulation. Frontiers Media S.A. 2018-12-04 /pmc/articles/PMC6288297/ /pubmed/30564201 http://dx.doi.org/10.3389/fmicb.2018.02856 Text en Copyright © 2018 Abatemarco Júnior, Sandes, Ricci, Arantes, Nunes, Nicoli and Neumann. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Abatemarco Júnior, Mario Sandes, Sávio Henrique Cicco Ricci, Mayra Fernanda Arantes, Rosa Maria Esteves Nunes, Álvaro Cantini Nicoli, Jacques Robert Neumann, Elisabeth Protective Effect of Lactobacillus diolivorans 1Z, Isolated From Brazilian Kefir, Against Salmonella enterica Serovar Typhimurium in Experimental Murine Models |
title | Protective Effect of Lactobacillus diolivorans 1Z, Isolated From Brazilian Kefir, Against Salmonella enterica Serovar Typhimurium in Experimental Murine Models |
title_full | Protective Effect of Lactobacillus diolivorans 1Z, Isolated From Brazilian Kefir, Against Salmonella enterica Serovar Typhimurium in Experimental Murine Models |
title_fullStr | Protective Effect of Lactobacillus diolivorans 1Z, Isolated From Brazilian Kefir, Against Salmonella enterica Serovar Typhimurium in Experimental Murine Models |
title_full_unstemmed | Protective Effect of Lactobacillus diolivorans 1Z, Isolated From Brazilian Kefir, Against Salmonella enterica Serovar Typhimurium in Experimental Murine Models |
title_short | Protective Effect of Lactobacillus diolivorans 1Z, Isolated From Brazilian Kefir, Against Salmonella enterica Serovar Typhimurium in Experimental Murine Models |
title_sort | protective effect of lactobacillus diolivorans 1z, isolated from brazilian kefir, against salmonella enterica serovar typhimurium in experimental murine models |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288297/ https://www.ncbi.nlm.nih.gov/pubmed/30564201 http://dx.doi.org/10.3389/fmicb.2018.02856 |
work_keys_str_mv | AT abatemarcojuniormario protectiveeffectoflactobacillusdiolivorans1zisolatedfrombraziliankefiragainstsalmonellaentericaserovartyphimuriuminexperimentalmurinemodels AT sandessaviohenriquecicco protectiveeffectoflactobacillusdiolivorans1zisolatedfrombraziliankefiragainstsalmonellaentericaserovartyphimuriuminexperimentalmurinemodels AT riccimayrafernanda protectiveeffectoflactobacillusdiolivorans1zisolatedfrombraziliankefiragainstsalmonellaentericaserovartyphimuriuminexperimentalmurinemodels AT arantesrosamariaesteves protectiveeffectoflactobacillusdiolivorans1zisolatedfrombraziliankefiragainstsalmonellaentericaserovartyphimuriuminexperimentalmurinemodels AT nunesalvarocantini protectiveeffectoflactobacillusdiolivorans1zisolatedfrombraziliankefiragainstsalmonellaentericaserovartyphimuriuminexperimentalmurinemodels AT nicolijacquesrobert protectiveeffectoflactobacillusdiolivorans1zisolatedfrombraziliankefiragainstsalmonellaentericaserovartyphimuriuminexperimentalmurinemodels AT neumannelisabeth protectiveeffectoflactobacillusdiolivorans1zisolatedfrombraziliankefiragainstsalmonellaentericaserovartyphimuriuminexperimentalmurinemodels |